IP Library › Granted Patent US 12,357,755
Granted Patent B2
US 12,357,755 · App. 17/125,009 · Granted Jul 15, 2025

Fluid management system and method for controlling intracavity pressure

Inventors: Leah Fanning (Clonmel, IE); Paul Byrne (Kilkenny, IE); Niraj Prasad Rauniyar (Plymouth, MN); Evan Gyllenhaal (Sudbury, MA); Vivek Shah (Reading, MA); Nishant Khattar (White Bear Township, MN); Noel Smith (County Kilkenny, IE)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61M5/1723A61M5/142A61B1/015A61M3/0216A61M3/022A61M2205/3331A61M2205/3334A61M2205/502A61M2205/583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,755
App. No.
17/125,009
Granted
Jul 15, 2025
Kind
B2
Abstract

A fluid management system may include an inflow pump configured to pump fluid from a fluid supply source to a treatment site within a patient at a flow rate; and a controller configured to operate at a target flow rate in a flow control mode. In the flow control mode, the controller may be configured to maintain the target flow rate while monitoring a measured pressure communicated to the controller from a pressure sensor. When the measured pressure reaches a preset pressure threshold, the controller may be configured to automatically switch from the flow control mode to a pressure override mode in which the controller automatically reduces the flow rate below the target flow rate to return the measured pressure at or below the preset pressure threshold.

Claims (33)

1. A fluid management system, comprising:

an inflow pump configured to pump fluid from a fluid supply source to a treatment site within a patient at a flow rate; and

a controller configured to operate at a target flow rate in a flow control mode;

wherein in the flow control mode, the controller is configured to maintain the target flow rate while monitoring a measured pressure communicated to the controller from a pressure sensor;

wherein when the measured pressure reaches a preset pressure threshold, the controller is configured to automatically switch from the flow control mode to a pressure override mode in which the controller automatically reduces the flow rate below the target flow rate while still pumping fluid to the treatment site to return the measured pressure at or below the preset pressure threshold.

2. The fluid management system of claim 1 , wherein the controller is configured to switch from the pressure override mode back to the flow control mode when the measured pressure falls below the preset pressure threshold.

3. The fluid management system of claim 2 , wherein the controller is configured to display a prompt on a display asking if a user wants to switch back to the flow control mode when the measured pressure falls below the preset pressure threshold.

4. The fluid management system of claim 2 , wherein the controller is configured to display a notification on a display and automatically switch from the pressure override mode back to the flow control mode when the measured pressure falls below the preset pressure threshold.

5. The fluid management system of claim 1 , wherein the controller is configured to switch from the pressure override mode to an adjusted flow control mode when the measured pressure falls below the preset pressure threshold.

6. The fluid management system of claim 5 , wherein the controller is configured to operate at the reduced flow rate of the pressure override mode when in the adjusted flow control mode.

7. The fluid management system of claim 5 , wherein the controller is configured to display a prompt on a display asking if a user wants to switch to the adjusted flow control mode when the measured pressure falls below the preset pressure threshold.

8. The fluid management system of claim 5 , wherein the controller is configured to display a notification on a display and automatically switch from the pressure override mode to the adjusted flow control mode when the measured pressure falls below the preset pressure threshold.

9. The fluid management system of claim 1 , wherein the measured pressure is an intracavity pressure measured within the treatment site.

10. The fluid management system of claim 9 , wherein the preset pressure threshold is an intracavity pressure limit.

11. The fluid management system of claim 1 , wherein the measured pressure is a system pressure measured within the fluid management system.

12. The fluid management system of claim 11 , wherein the preset pressure threshold is a system pressure limit.

13. A fluid management system, comprising:

an inflow pump configured to pump fluid from a fluid supply source to a treatment site within a patient at a flow rate; and

a controller configured to operate at a target flow rate in a flow control mode;

wherein in the flow control mode, the controller is configured to maintain the target flow rate while monitoring a measured pressure communicated to the controller from a pressure sensor;

wherein when the measured pressure reaches a preset pressure threshold, the controller is configured to automatically switch from the flow control mode to a pressure override mode in which the controller automatically reduces the flow rate below the target flow rate while still pumping fluid to the treatment site to return the measured pressure at or below the preset pressure threshold;

wherein the controller is configured to display a prompt on a display asking if a user wants to switch out of the pressure override mode when the measured pressure falls below the preset pressure threshold.

14. The fluid management system of claim 13 , wherein the controller is configured to switch from the pressure override mode back to the flow control mode when the measured pressure falls below the preset pressure threshold.

15. The fluid management system of claim 13 , wherein the controller is configured to switch from the pressure override mode to an adjusted flow control mode when the measured pressure falls below the preset pressure threshold.

16. The fluid management system of claim 15 , wherein in the adjusted flow control mode, the flow rate is thereafter maintained at the reduced flow rate associated with the pressure override mode.

17. The fluid management system of claim 13 , wherein the prompt asks if the user wants to switch back to the flow control mode or to an adjusted flow control mode.

18. A method of controlling fluid flow in a fluid management system, wherein the fluid management system comprises an inflow pump configured to pump fluid from a fluid supply source to a treatment site within a patient at a flow rate and a controller configured to operate at a target flow rate in a flow control mode, the method comprising:

setting parameters within the controller, wherein the parameters include the target flow rate and a preset pressure threshold;

operating the controller in the flow control mode, wherein the controller maintains the target flow rate while monitoring a measured pressure communicated to the controller from a pressure sensor;

when the measured pressure reaches the preset pressure threshold, automatically switching the controller from the flow control mode to a pressure override mode in which the controller automatically reduces the flow rate below the target flow rate while still pumping fluid to the treatment site to return the measured pressure at or below the preset pressure threshold; and

displaying a prompt on a display asking if a user wants to switch out of the pressure override mode when the measured pressure falls below the preset pressure threshold.

19. The method of claim 18 , wherein the preset pressure threshold is an intracavity pressure limit.

20. The method of claim 18 , wherein the preset pressure threshold is a system pressure limit.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2020
From: FANNING, LEAH; BYRNE, PAUL; RAUNIYAR, NIRAJ PRASAD; GYLLENHAAL, EVAN; SHAH, VIVEK; KHATTAR, NISHANT; SMITH, NOEL
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 054681/0840 →
Continuity (2)
Provisional Application 62967806 · Jan 30, 2020
Related Publication 20210236728A1 · Aug 5, 2021
References Cited (102)
US 4526574A · Pekkarinen · 1985 [cited by applicant]
US 4650462A · Desatnick et al. · 1987 [cited by applicant]
US 4998914A · Wiest et al. · 1991 [cited by applicant]
US 5460490A · Carr et al. · 1995 [cited by applicant]
US 5464391A · Devale · 1995 [cited by applicant]
US 5630798A · Beiser et al. · 1997 [cited by applicant]
US 5685821A · Pike · 1997 [cited by applicant]
US 5709670A · Vancaille et al. · 1998 [cited by applicant]
US 5800383A · Chandler et al. · 1998 [cited by applicant]
US 5803917A · Butterfield · 1998 [cited by examiner]
US 5810770A · Chin et al. · 1998 [cited by applicant]
US 5830180A · Chandler et al. · 1998 [cited by applicant]
US 5882339A · Beiser et al. · 1999 [cited by applicant]
US 6024720A · Chandler et al. · 2000 [cited by applicant]
US 6077246A · Kullas et al. · 2000 [cited by applicant]
US 6159160A · Hsei et al. · 2000 [cited by applicant]
US 6595957B1 · Griffiths et al. · 2003 [cited by applicant]
US 6896664B2 · Novak · 2005 [cited by applicant]
US 7083601B1 · Cosmescu · 2006 [cited by applicant]
US 7604610B2 · Shener et al. · 2009 [cited by applicant]
US 7981073B2 · Möllstam et al. · 2011 [cited by applicant]
US D657865S · Williams · 2012 [cited by applicant]
US 8444592B2 · Williams et al. · 2013 [cited by applicant]
US 8512326B2 · Shadduck et al. · 2013 [cited by applicant]
US 8597228B2 · Pyles et al. · 2013 [cited by applicant]
US 8728066B2 · Shadduck et al. · 2014 [cited by applicant]
US 8790303B2 · Williams et al. · 2014 [cited by applicant]
US 8795232B2 · Visconti et al. · 2014 [cited by applicant]
US 8974448B2 · Germain et al. · 2015 [cited by applicant]
US 9084847B2 · Klein et al. · 2015 [cited by applicant]
US 9233193B2 · Truckai et al. · 2016 [cited by applicant]
US 9247983B2 · Truckai et al. · 2016 [cited by applicant]
US 9254142B2 · Germain et al. · 2016 [cited by applicant]
US 9272086B2 · Williams et al. · 2016 [cited by applicant]
US 9289110B2 · Woolford et al. · 2016 [cited by applicant]
US 9322729B2 · Heide et al. · 2016 [cited by applicant]
US 9439677B2 · Germain et al. · 2016 [cited by applicant]
US 9439720B2 · Germain et al. · 2016 [cited by applicant]
US 9474848B2 · Williams et al. · 2016 [cited by applicant]
US 9486233B2 · Bek et al. · 2016 [cited by applicant]
US 9498244B2 · Orczy-Timko et al. · 2016 [cited by applicant]
US 9549754B2 · Shadduck et al. · 2017 [cited by applicant]
US 9597149B2 · Germain et al. · 2017 [cited by applicant]
US 9603990B2 · Woolford · 2017 [cited by applicant]
US 9636170B2 · Germain et al. · 2017 [cited by applicant]
US 9737362B2 · Germain et al. · 2017 [cited by applicant]
US 9743979B2 · Germain et al. · 2017 [cited by applicant]
US 9770541B2 · Carr et al. · 2017 [cited by applicant]
US 9827037B2 · Germain et al. · 2017 [cited by applicant]
US 9839473B2 · Germain et al. · 2017 [cited by applicant]
US 9889246B2 · Woolford · 2018 [cited by applicant]
US 9901665B2 · Klein et al. · 2018 [cited by applicant]
US 9907563B2 · Germain et al. · 2018 [cited by applicant]
US 9943639B2 · Germain et al. · 2018 [cited by applicant]
US 9999466B2 · Germain et al. · 2018 [cited by applicant]
US 10004556B2 · Orczy-Timko et al. · 2018 [cited by applicant]
US 10178942B2 · Germain et al. · 2019 [cited by applicant]
US 10238412B2 · Bek et al. · 2019 [cited by applicant]
US 10349815B2 · Germain et al. · 2019 [cited by applicant]
US 10368912B2 · Truckai et al. · 2019 [cited by applicant]
US 10441353B2 · Germain et al. · 2019 [cited by applicant]
US 10499987B2 · Germain et al. · 2019 [cited by applicant]
US 10518005B2 · Carr et al. · 2019 [cited by applicant]
US 10531785B2 · Germain et al. · 2020 [cited by applicant]
US 10531912B2 · Germain et al. · 2020 [cited by applicant]
US 10603104B2 · Germain et al. · 2020 [cited by applicant]
US 10667857B2 · Shadduck et al. · 2020 [cited by applicant]
US 10716584B2 · Germain et al. · 2020 [cited by applicant]
US 10751451B2 · Klein et al. · 2020 [cited by applicant]
US 10786619B2 · Germain et al. · 2020 [cited by applicant]
US 20080154095A1 · Stubkjaer et al. · 2008 [cited by applicant]
US 20120191037A1 · Patel et al. · 2012 [cited by applicant]
US 20120283691A1 · Barnes · 2012 [cited by examiner]
US 20130197471A1 · Williams et al. · 2013 [cited by applicant]
US 20130245599A1 · Williams et al. · 2013 [cited by applicant]
US 20130253498A1 · Germain et al. · 2013 [cited by applicant]
US 20140336599A1 · Patel et al. · 2014 [cited by applicant]
US 20150290404A1 · Torisawa et al. · 2015 [cited by applicant]
US 20150328379A1 · Carr et al. · 2015 [cited by applicant]
US 20170000957A1 · Carr et al. · 2017 [cited by applicant]
US 20170027637A1 · Germain et al. · 2017 [cited by applicant]
US 20170056102A1 · Germain et al. · 2017 [cited by applicant]
US 20170203028A1 · Carr et al. · 2017 [cited by applicant]
US 20180000998A1 · Carr et al. · 2018 [cited by applicant]
US 20180132930A1 · Germain et al. · 2018 [cited by applicant]
US 20180168667A1 · Germain · 2018 [cited by examiner]
US 20180207332A1 · Reever et al. · 2018 [cited by applicant]
US 20180271596A1 · Germain et al. · 2018 [cited by applicant]
US 20180361055A1 · Pereira et al. · 2018 [cited by applicant]
US 20190175204A1 · Bek et al. · 2019 [cited by applicant]
US 20190321096A1 · Germain et al. · 2019 [cited by applicant]
US 20190336166A1 · Truckai et al. · 2019 [cited by applicant]
US 20200100836A1 · Germain et al. · 2020 [cited by applicant]
US 20200121387A1 · Germain et al. · 2020 [cited by applicant]
US 20200246067A1 · Germain et al. · 2020 [cited by applicant]
US 20200281645A1 · Shadduck et al. · 2020 [cited by applicant]
US 20200315640A1 · Germain et al. · 2020 [cited by applicant]
CN 1200741C · 2005 [cited by applicant]
EP 0329599A1 · 1989 [cited by applicant]
FR 2727847A1 · 1996 [cited by applicant]
JP H07178044A · 1995 [cited by applicant]
International Search Report and Written Opinion dated Apr. 8, 2021 for International Application No. PCT/US2020/065568. [cited by applicant]